Prapela
Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns.
Biddeford, United States
4 employees
Grant
Total: $8.18M
Health Care, Health and Wellness +1
General Information
Get notified when Prapela moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Prapela
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About Prapela
Taxonomy: noninvasive stimulation therapy, newborn health, pediatric medical device, neonatology, apnea of prematurity, neonatal abstinence syndrome, intermittent hypoxemia, infant sleep, respiratory syncytial virus, medical device startup, neonatal intensive care, oxygenation, babies health, grants funding, FDA collaboration
Funding Rounds & Investors (15)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 | •••• •••• | 19 Dec 2023 |
| Grant | •••••• | 1 | •••• •••• | 10 Mar 2023 |
| Grant | •••••• | 1 | •••• •••• | 20 May 2021 |
| Grant | •••••• | 1 |
|
20 Apr 2021 |
| Non Equity Assistance | •••••• | 1 | •••• •••• | 11 Nov 2020 |
Prapela Alternatives & Competitors
The patented AmnioBed™ is intended to improve clinical outcomes for preterm birth (PTB) infants
Developing innovative solutions for the well-being of newborns
FAQ About Prapela
Don't just browse. Track.
Signal Tracker monitors Prapela and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
